www.biopharmaboardroom.com Open in urlscan Pro
2a02:4780:3:644:0:683:abf2:5  Public Scan

Submitted URL: https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.htm...
Submission: On March 13 via api from DE — Scanned from DE

Summary

This website contacted 8 IPs in 3 countries across 8 domains to perform 70 HTTP transactions. The main IP is 2a02:4780:3:644:0:683:abf2:5, located in Singapore, Singapore and belongs to AS-HOSTINGER, CY. The main domain is www.biopharmaboardroom.com.
TLS certificate: Issued by R3 on January 18th 2024. Valid for: 3 months.
This is the only time www.biopharmaboardroom.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

Apex Domain
Subdomains
Transfer
46 biopharmaboardroom.com
www.biopharmaboardroom.com
3 MB
9 gstatic.com
www.gstatic.com
1 MB
9 google.com
www.google.com — Cisco Umbrella Rank: 2
77 KB
3 twitter.com
platform.twitter.com — Cisco Umbrella Rank: 1306
syndication.twitter.com — Cisco Umbrella Rank: 1683
132 KB
1 google-analytics.com
region1.google-analytics.com — Cisco Umbrella Rank: 2089
262 B
1 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 40
97 KB
1 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 30
1 KB
1 dripemail2.com
t.dripemail2.com — Cisco Umbrella Rank: 181280
272 B
70 8
Domain Requested by
46 www.biopharmaboardroom.com www.biopharmaboardroom.com
9 www.gstatic.com www.google.com
9 www.google.com www.biopharmaboardroom.com
www.gstatic.com
www.google.com
2 platform.twitter.com www.biopharmaboardroom.com
platform.twitter.com
1 syndication.twitter.com platform.twitter.com
1 region1.google-analytics.com www.googletagmanager.com
1 www.googletagmanager.com www.biopharmaboardroom.com
1 fonts.googleapis.com www.biopharmaboardroom.com
1 t.dripemail2.com 1 redirects
70 9
Subject Issuer Validity Valid
biopharmaboardroom.com
R3
2024-01-18 -
2024-04-17
3 months crt.sh
upload.video.google.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
www.google.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
*.twimg.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-07-28 -
2024-07-26
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
syndication.twitter.com
R3
2024-02-21 -
2024-05-21
3 months crt.sh
*.google.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh

This page contains 6 frames:

Primary Page: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Frame ID: 520E1334A9D6AFDA3574B1BB27A22637
Requests: 52 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fwww.biopharmaboardroom.com
Frame ID: 8C48D02515AAAC3C7FC8C360CA0B05DB
Requests: 2 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=6d127scxyv0o
Frame ID: 61A3061FF39D7868083DD9412645B385
Requests: 5 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=58dotlukdv3d
Frame ID: 583E29BA25B8334CCDDCC910C5BB2770
Requests: 5 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Frame ID: 41E7EAD49330DBEC91BDE4116B256627
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Frame ID: AAA7EA4FF4FF790D941C3CFF75313988
Requests: 3 HTTP requests in this frame

Screenshot

Page Title

Fujifilm Owen Technology Products Approved, Expanding Reproductive Tech in China

Page URL History Show full URLs

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
    https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproducti... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
  • bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • \bangular.{0,32}\.js

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • ([\d.]+)?/modernizr(?:\.([\d.]+))?.*\.js


Overall confidence: 100%
Detected patterns
  • //platform\.twitter\.com/widgets\.js

Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • /recaptcha/api\.js

Page Statistics

70
Requests

100 %
HTTPS

78 %
IPv6

8
Domains

9
Subdomains

8
IPs

3
Countries

4017 kB
Transfer

6847 kB
Size

3
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzA5MDIxNDY3LCJuYmYiOjE3MDkwMjE0NjcsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiJ0b2JmYmJvaWNjdGY3bjBkeHF3ZSIsInVybCI6Imh0dHBzOi8vd3d3LmJpb3BoYXJtYWJvYXJkcm9vbS5jb20vbmV3cy81Ni8xNjMxL2Z1amlmaWxtLW93ZW4tdGVjaG5vbG9neS1wcm9kdWN0cy1hcHByb3ZlZC1leHBhbmRpbmctcmVwcm9kdWN0aXZlLXRlY2gtaW4tY2hpbmEuaHRtbD9fX3M9NXNsdnFmZjZ3djJtN202ZTJsOWkmdXRtX3NvdXJjZT1kcmlwJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPVRha2VkYSthbmQrQmlvbG9naWNhbCtFLitMaW1pdGVkK1BhcnRuZXIrdG8rRW5oYW5jZStEZW5ndWUrVmFjY2luZStBdmFpbGFiaWxpdHkraW4rSGlnaC1SaXNrK1JlZ2lvbnMifQ.eU1xGA9--RNiEQV3EAwUxM0MnPIHwV13YDjvZIDKhmE HTTP 307
    https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

70 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html
www.biopharmaboardroom.com/news/56/1631/
Redirect Chain
  • https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzA5MDIxNDY3LCJuYmYiOjE3MDkwMjE0NjcsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
  • https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_ca...
59 KB
16 KB
Document
General
Full URL
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed / PHP/7.0.33
Resource Hash
8f45c865c8be9dd1a767cba38682c1a12dba47293e0a81ee077de1fcc265b286
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
cache-control
no-cache
content-encoding
br
content-security-policy
upgrade-insecure-requests
content-type
text/html; charset=UTF-8
date
Wed, 13 Mar 2024 07:46:17 GMT
platform
hostinger
server
LiteSpeed
vary
Accept-Encoding
x-powered-by
PHP/7.0.33

Redirect headers

content-length
0
date
Wed, 13 Mar 2024 07:46:16 GMT
location
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
css2
fonts.googleapis.com/
7 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Montserrat:wght@400;500;600;700&display=swap
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:803::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
156d6126d329168667f3fc9fd67a12202eae1ac3619318e0fff058fb74944c1d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Wed, 13 Mar 2024 07:21:59 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 13 Mar 2024 07:46:17 GMT
bootstrap.min.css
www.biopharmaboardroom.com/bundles/taai/app/site/css/
158 KB
21 KB
Stylesheet
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/bootstrap.min.css
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
7f20b0f336731d4e5773dc2ed35d7ebc0cb9729fc2a2eba66719b5bd73944e41
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:45 GMT
server
LiteSpeed
etag
"279d8-641efd25-82e73e42b8cdeeb4;br"
vary
Accept-Encoding
content-type
text/css
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
21246
expires
Wed, 20 Mar 2024 07:46:17 GMT
all.min.css
www.biopharmaboardroom.com/bundles/taai/app/site/css/
58 KB
12 KB
Stylesheet
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/all.min.css
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
14cbd9b866a9b092e3a2e03a93b128da5baca005fd8b44a1956146eaab7b48b7
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sun, 26 Mar 2023 12:54:03 GMT
server
LiteSpeed
etag
"e637-6420406b-9e4b9af9255a943a;br"
vary
Accept-Encoding
content-type
text/css
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
12207
expires
Wed, 20 Mar 2024 07:46:17 GMT
style.css
www.biopharmaboardroom.com/bundles/taai/app/site/css/
173 KB
22 KB
Stylesheet
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/style.css
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
b792505e78c8eb498b6168ff0a95ae94ea6595f4229d6cc047a62851e98cd32d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Tue, 27 Jun 2023 05:07:55 GMT
server
LiteSpeed
etag
"2b37d-649a6eab-e7f2fd49235fa0d3;br"
vary
Accept-Encoding
content-type
text/css
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
22067
expires
Wed, 20 Mar 2024 07:46:17 GMT
custom-style.css
www.biopharmaboardroom.com/bundles/taai/app/site/css/
11 KB
2 KB
Stylesheet
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/custom-style.css
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
cddb595c8411b5dc9e6873115d39370a7d2cf12c7fa1ca6a33f30054e13d26dc
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Fri, 31 Mar 2023 07:04:53 GMT
server
LiteSpeed
etag
"2ab4-64268615-de433fd54aaf912b;br"
vary
Accept-Encoding
content-type
text/css
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
2345
expires
Wed, 20 Mar 2024 07:46:17 GMT
logo.svg
www.biopharmaboardroom.com/bundles/taai/app/site/img/
28 KB
8 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/img/logo.svg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
30f1f3aa7becd53a814521c58c1741a92b7a73cccf823bc640782936be0285ee
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:50 GMT
server
LiteSpeed
etag
"6ff5-641efd2a-4b8f33bc32f2c51e;br"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
8184
expires
Wed, 20 Mar 2024 07:46:17 GMT
17532612721779960119-21.gif
www.biopharmaboardroom.com/uploads/static/
83 KB
83 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/static/17532612721779960119-21.gif
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
af73f39b060861e7f8b845aa688ddc952b6571c1434d2573b2b0dc87fb4d2728
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Thu, 18 May 2023 03:48:47 GMT
server
LiteSpeed
etag
"14cbc-6465a01f-ab4964fe5deca1a6;;;"
content-type
image/gif
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
85180
expires
Wed, 20 Mar 2024 07:46:17 GMT
fisi_art_cn_family-1631.jpg
www.biopharmaboardroom.com/uploads/articles/
57 KB
58 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/fisi_art_cn_family-1631.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
3d82db18ac16682b0e72e715501fa1afdc0f817fce3c2981eb8354b2ea13ea8b
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Tue, 27 Feb 2024 07:52:24 GMT
server
LiteSpeed
etag
"e58f-65dd94b8-8ffc91e76b6642f0;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
58767
expires
Wed, 20 Mar 2024 07:46:17 GMT
a304da6d3ccc09b7b0cefc506af41c41-24.png
www.biopharmaboardroom.com/uploads/static/
186 KB
186 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/static/a304da6d3ccc09b7b0cefc506af41c41-24.png
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
5636db9bbcf1d84438d12d3b60dfc801712f7d2bb17b20200c011153d85bfebe
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Tue, 05 Mar 2024 10:35:04 GMT
server
LiteSpeed
etag
"2e8c3-65e6f558-468298d671443bce;;;"
content-type
image/png
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
190659
expires
Wed, 20 Mar 2024 07:46:17 GMT
14780814552302417923-25.jpeg
www.biopharmaboardroom.com/uploads/static/
60 KB
60 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/static/14780814552302417923-25.jpeg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
3bd006e07aae202fdcccfb09ddf4e861e7e296249957caa9b85f0fbec55a5394
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Tue, 05 Mar 2024 10:36:20 GMT
server
LiteSpeed
etag
"f05f-65e6f5a4-fdfbca08b6684f0a;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
61535
expires
Wed, 20 Mar 2024 07:46:17 GMT
7579954952323518077-26.jpeg
www.biopharmaboardroom.com/uploads/static/
61 KB
61 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/static/7579954952323518077-26.jpeg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
fa1caf050060c9264e63661a5cebad16e5c3ba98542b3074144c319b65e38fe9
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Tue, 05 Mar 2024 10:37:21 GMT
server
LiteSpeed
etag
"f284-65e6f5e1-25fda1745a065764;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
62084
expires
Wed, 20 Mar 2024 07:46:17 GMT
433327332048189618-27.png
www.biopharmaboardroom.com/uploads/static/
70 KB
71 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/static/433327332048189618-27.png
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
a9d72bc56e3aacf007e0559595b1028eb5938364a56dba071172355658f94d2a
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Tue, 05 Mar 2024 10:38:31 GMT
server
LiteSpeed
etag
"1199b-65e6f627-6d88b48e18e2b3eb;;;"
content-type
image/png
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
72091
expires
Wed, 20 Mar 2024 07:46:17 GMT
1695969403_tfs_beyond_beaker_drum-28.png
www.biopharmaboardroom.com/uploads/static/
141 KB
141 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/static/1695969403_tfs_beyond_beaker_drum-28.png
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
8bf568ce2654ca0bdd149b9adeb30b22d6afecf432dd543d7a86ab49838abec9
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 28 Oct 2023 05:08:10 GMT
server
LiteSpeed
etag
"232f1-653c973a-416b1904f70297f1;;;"
content-type
image/png
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
144113
expires
Wed, 20 Mar 2024 07:46:17 GMT
screenshot_2024_02_13_at_12_23_38_pm-1587.jpg
www.biopharmaboardroom.com/uploads/articles/
287 KB
287 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/screenshot_2024_02_13_at_12_23_38_pm-1587.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
d89da8dd1cee57d3f8b558770d23e6fd3c81290014e5e51ba0c9709c4a47bca4
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Tue, 13 Feb 2024 06:54:47 GMT
server
LiteSpeed
etag
"47b1c-65cb1237-f0757871ddec244;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
293660
expires
Wed, 20 Mar 2024 07:46:17 GMT
top_7_challenges_faced_by_pharma_ai-1341.jpg
www.biopharmaboardroom.com/uploads/articles/
184 KB
184 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/top_7_challenges_faced_by_pharma_ai-1341.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
ad86638acb2a489a67072a185e40cc3bf3c901d5d5f0e200604acaa90effa14e
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sun, 03 Dec 2023 14:50:00 GMT
server
LiteSpeed
etag
"2debb-656c9598-f861ad5b780658a1;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
188091
expires
Wed, 20 Mar 2024 07:46:17 GMT
54782_blg_software_blog_1-1202.jpg
www.biopharmaboardroom.com/uploads/articles/
265 KB
265 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/54782_blg_software_blog_1-1202.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
097d1099a0795ef3734a7d20661e99e79e2a343abf720e6831ff5976b714b082
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sun, 22 Oct 2023 19:56:08 GMT
server
LiteSpeed
etag
"42223-65357e58-e2f6424a1a854ef7;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
270883
expires
Wed, 20 Mar 2024 07:46:17 GMT
final_catalent_linkedin_post_image-1574.jpg
www.biopharmaboardroom.com/uploads/articles/
129 KB
130 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/final_catalent_linkedin_post_image-1574.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
cdcbd57bc29fe889cbe45d07b2afc4c4337c62fa2cb16c820cc9c3f7cf3508f7
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Thu, 08 Feb 2024 18:24:36 GMT
server
LiteSpeed
etag
"205b2-65c51c64-4b7db832cbf1d288;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
132530
expires
Wed, 20 Mar 2024 07:46:17 GMT
accelerator_illumina_062822-1487.jpg
www.biopharmaboardroom.com/uploads/articles/
40 KB
40 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/accelerator_illumina_062822-1487.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
c91a3acd10f70b7b3eeac44efef0026cc4c2bddcd0b78eb21cd2ce665d2a41da
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Fri, 12 Jan 2024 17:09:29 GMT
server
LiteSpeed
etag
"9fdd-65a17249-def8584dc8a7be0d;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
40925
expires
Wed, 20 Mar 2024 07:46:17 GMT
bffa23ec729d2a1111fef49781391d47cc9ac5ab_1280x720-1459.jpg
www.biopharmaboardroom.com/uploads/articles/
118 KB
118 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/bffa23ec729d2a1111fef49781391d47cc9ac5ab_1280x720-1459.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
1446435ed27928886321e7cc573eca43b9b32cd25ca4f069e45e167849471186
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Fri, 05 Jan 2024 10:38:40 GMT
server
LiteSpeed
etag
"1d879-6597dc30-e578e9c8be087eac;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
120953
expires
Wed, 20 Mar 2024 07:46:17 GMT
images-1336.jpeg
www.biopharmaboardroom.com/uploads/articles/
7 KB
7 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/images-1336.jpeg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
e5592be14d488a138bd023392b0769abe2ac0f5b5caf926347469232b30dcc41
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Wed, 29 Nov 2023 03:58:27 GMT
server
LiteSpeed
etag
"1aad-6566b6e3-65c96325f171cf3e;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
6829
expires
Wed, 20 Mar 2024 07:46:18 GMT
dna_jump_x_pe51u6qg5p4akhcbepbhte4ly6vy0foob896hafvte-1287.jpg
www.biopharmaboardroom.com/uploads/articles/
31 KB
31 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/dna_jump_x_pe51u6qg5p4akhcbepbhte4ly6vy0foob896hafvte-1287.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
ad1c04e2cbff064238f0d47a51df1d650866874742c11e6f409e657ffd700c2a
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Thu, 16 Nov 2023 15:20:38 GMT
server
LiteSpeed
etag
"7b8f-65563346-63d6b424f983626e;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
31631
expires
Wed, 20 Mar 2024 07:46:18 GMT
maselli_alessandro-1581.jpg
www.biopharmaboardroom.com/uploads/articles/
27 KB
27 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/maselli_alessandro-1581.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
0d550bd238cbb62a201b7e0d768a132d2c9fa7f1a8d71164d7e28aff55c285f5
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Mon, 12 Feb 2024 05:01:38 GMT
server
LiteSpeed
etag
"6c85-65c9a632-522a789905eba9e6;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
27781
expires
Wed, 20 Mar 2024 07:46:18 GMT
unknown_1-1580.jpeg
www.biopharmaboardroom.com/uploads/articles/
4 KB
4 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/unknown_1-1580.jpeg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
052113bd49224770313f9f261cfc44ee5eb0d9a1753e22bcf925336dc5af3748
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Fri, 09 Feb 2024 09:36:59 GMT
server
LiteSpeed
etag
"e4c-65c5f23b-46af80784cfc8e97;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
3660
expires
Wed, 20 Mar 2024 07:46:18 GMT
unknown-1571.jpeg
www.biopharmaboardroom.com/uploads/articles/
5 KB
5 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/unknown-1571.jpeg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
c4600f33b281058405b0ed63bb0c81ce1fb70132213a1786699080408d85d470
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Thu, 08 Feb 2024 13:22:21 GMT
server
LiteSpeed
etag
"120b-65c4d58d-11bc5c36770b982b;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
4619
expires
Wed, 20 Mar 2024 07:46:18 GMT
christopher_boerner-1561.jpg
www.biopharmaboardroom.com/uploads/articles/
19 KB
19 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/christopher_boerner-1561.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
e8eeeab285f481784ec431053383b8ffafff61222712434d149ef5e62fffc4bd
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Mon, 05 Feb 2024 06:50:35 GMT
server
LiteSpeed
etag
"4a5c-65c0853b-86f720a99e8684d6;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
19036
expires
Wed, 20 Mar 2024 07:46:18 GMT
amit_choprafinal_795_x_500_px-1555.png
www.biopharmaboardroom.com/uploads/articles/
220 KB
220 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/amit_choprafinal_795_x_500_px-1555.png
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
7265d36a4ce8cd2dfb2fa98277d2d3637c914b67f9120a099a133c09a78c4fbf
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Fri, 02 Feb 2024 15:15:00 GMT
server
LiteSpeed
etag
"37025-65bd06f4-9bfa5aa4b2356292;;;"
content-type
image/png
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
225317
expires
Wed, 20 Mar 2024 07:46:18 GMT
images-1549.jpeg
www.biopharmaboardroom.com/uploads/articles/
31 KB
31 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/images-1549.jpeg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
e772321caa4c4b2ef1a12bdb39a6da3e242c2aa143013e144710a8dd6d42011e
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Wed, 31 Jan 2024 11:07:13 GMT
server
LiteSpeed
etag
"7c98-65ba29e1-dff8a1ffa44be049;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
31896
expires
Wed, 20 Mar 2024 07:46:18 GMT
unknown_1203-1544.jpeg
www.biopharmaboardroom.com/uploads/articles/
6 KB
6 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/uploads/articles/unknown_1203-1544.jpeg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
abb88e90bbd562aade6c7aa43e3d11ae616031f5c73db85b08067030217c6aaf
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Wed, 31 Jan 2024 09:35:36 GMT
server
LiteSpeed
etag
"16d5-65ba1468-e27842e99a3b8b26;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
5845
expires
Wed, 20 Mar 2024 07:46:18 GMT
ajax-loading.gif
www.biopharmaboardroom.com/bundles/taai/assets/global/img/
29 KB
29 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/assets/global/img/ajax-loading.gif
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
9eb442caf593ea96298bcb44a7fb79f24c414ceeece61aea0357e44008889602
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:55:04 GMT
server
LiteSpeed
etag
"7507-641efd38-c4029b0d2bd507ba;;;"
content-type
image/gif
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
29959
expires
Wed, 20 Mar 2024 07:46:18 GMT
jquery-3.4.1.min.js
www.biopharmaboardroom.com/bundles/taai/app/site/js/
86 KB
29 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/js/jquery-3.4.1.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
0925e8ad7bd971391a8b1e98be8e87a6971919eb5b60c196485941c3c1df089a
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sun, 26 Mar 2023 11:19:28 GMT
server
LiteSpeed
etag
"15851-64202a40-3dfc431dfa5aff5e;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
29817
expires
Wed, 20 Mar 2024 07:46:17 GMT
bootstrap.bundle.min.js
www.biopharmaboardroom.com/bundles/taai/app/site/js/
79 KB
21 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/js/bootstrap.bundle.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
394156ee114ed3faf968419340ecfd17f69740eb7e4f0a88d59e1f6d5bf0c34e
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sun, 26 Mar 2023 11:21:36 GMT
server
LiteSpeed
etag
"13b3a-64202ac0-8e4613528b8af9c8;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
21583
expires
Wed, 20 Mar 2024 07:46:17 GMT
modernizr.min.js
www.biopharmaboardroom.com/bundles/taai/app/site/js/
11 KB
4 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/js/modernizr.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
d2b82e612d2a812e8be2a57300dab8923c4f2edbe7a799e7da70791b595646fe
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:58 GMT
server
LiteSpeed
etag
"2b4c-641efd32-762ff7c9ad7efda6;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
4227
expires
Wed, 20 Mar 2024 07:46:17 GMT
jquery.autoscroll.js
www.biopharmaboardroom.com/bundles/taai/app/site/js/
1 KB
651 B
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/js/jquery.autoscroll.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:56 GMT
server
LiteSpeed
etag
"59b-641efd30-9021d31b4c5188b4;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
565
expires
Wed, 20 Mar 2024 07:46:17 GMT
easing.min.js
www.biopharmaboardroom.com/bundles/taai/app/site/lib/easing/
2 KB
821 B
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/lib/easing/easing.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
0ec98adf593ebcc01bec60b1f494dacd47522abfef9038a714101d83f45e165d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:55:50 GMT
server
LiteSpeed
etag
"8fe-641efd66-966caab68c78f498;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
735
expires
Wed, 20 Mar 2024 07:46:17 GMT
owl.carousel.min.js
www.biopharmaboardroom.com/bundles/taai/app/site/lib/owlcarousel/
42 KB
10 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/lib/owlcarousel/owl.carousel.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
b394d33b2a7ec654a6b037ebfda6618341b3f897a362be624c923c2711b54a43
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Wed, 12 Apr 2023 07:49:16 GMT
server
LiteSpeed
etag
"a70e-6436627c-605e7e54bec01121;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
10506
expires
Wed, 20 Mar 2024 07:46:17 GMT
main.js
www.biopharmaboardroom.com/bundles/taai/app/site/js/
9 KB
2 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/js/main.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
0eee8fab2c0f5a60797f3b16c5fce20be942081041ae7acc4950f6dbfacc7200
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Mon, 10 Apr 2023 14:31:35 GMT
server
LiteSpeed
etag
"24bf-64341dc7-3175e5c334997402;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
2033
expires
Wed, 20 Mar 2024 07:46:17 GMT
dips-site-common.js
www.biopharmaboardroom.com/bundles/taai/app/site/js/
5 KB
2 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/js/dips-site-common.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:55 GMT
server
LiteSpeed
etag
"13f4-641efd2f-afad7c726de47444;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
1639
expires
Wed, 20 Mar 2024 07:46:17 GMT
api.js
www.google.com/recaptcha/
1 KB
1 KB
Script
General
Full URL
https://www.google.com/recaptcha/api.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
3252500be7b91b993ef2af4039c11871773ea1dbda57868f3dbfcd388eb2a66d
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Wed, 13 Mar 2024 07:46:17 GMT
angular.min.js
www.biopharmaboardroom.com/bundles/taai/assets/global/plugins/angularjs/
144 KB
49 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/assets/global/plugins/angularjs/angular.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
e98bbb47c8a8d2c10536daedcad637a90b0b9dac1ebdaff89b6e59ab9cf55d4f
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:56:41 GMT
server
LiteSpeed
etag
"24117-641efd99-216796b4030ad2b3;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
50474
expires
Wed, 20 Mar 2024 07:46:17 GMT
angular-route.min.js
www.biopharmaboardroom.com/bundles/taai/assets/global/plugins/angularjs/
4 KB
2 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/assets/global/plugins/angularjs/angular-route.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
a4c9e1d1951c0b4eaa68436a7f0c562ec58afc092188c94856a7653d703b06c5
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:56:37 GMT
server
LiteSpeed
etag
"1126-641efd95-3170f9976030a9cf;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
1938
expires
Wed, 20 Mar 2024 07:46:17 GMT
SitePollController.js
www.biopharmaboardroom.com/bundles/taai/app/site/js/
1 KB
553 B
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/js/SitePollController.js?20240313131617000000
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
55c1dce99c493aaf1d9f8c152205d2855f07cc9ed5b76e75da905c0c6b31645b
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Thu, 22 Jun 2023 12:17:57 GMT
server
LiteSpeed
etag
"53a-64943bf5-74ee9451a379a89f;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
467
expires
Wed, 20 Mar 2024 07:46:17 GMT
widgets.js
platform.twitter.com/
91 KB
28 KB
Script
General
Full URL
https://platform.twitter.com/widgets.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2606:2800:234:46c:e8b:1e2f:2bd:694 , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (frb/6776) /
Resource Hash
173460e89e6a7244218badae2016f65c48a3eae9d400802273eeca18b07336f1

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

Date
Wed, 13 Mar 2024 07:46:17 GMT
Content-Encoding
gzip
Age
720
x-amz-server-side-encryption
AES256
X-Cache
HIT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Content-Length
27597
Last-Modified
Mon, 11 Dec 2023 17:20:28 GMT
Server
ECS (frb/6776)
Etag
"824beb891744db98ccbd3a456e59e0f7+gzip"
Access-Control-Max-Age
3000
Access-Control-Allow-Methods
GET
Content-Type
application/javascript; charset=utf-8
Access-Control-Allow-Origin
*
x-tw-cdn
VZ
Cache-Control
public, max-age=1800
Vary
Accept-Encoding
articulate.min.js
www.biopharmaboardroom.com/bundles/taai/assets/global/plugins/text-to-speech/
8 KB
2 KB
Script
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/assets/global/plugins/text-to-speech/articulate.min.js
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:57:00 GMT
server
LiteSpeed
etag
"1e7c-641efdac-115f90403cc007d6;br"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
2410
expires
Wed, 20 Mar 2024 07:46:17 GMT
js
www.googletagmanager.com/gtag/
293 KB
97 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-PHNZRXFXEX
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/news/56/1631/fujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Takeda+and+Biological+E.+Limited+Partner+to+Enhance+Dengue+Vaccine+Availability+in+High-Risk+Regions
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
a3475b6117600d45b4fc7c1c70c4c103868d8a14501759cc57127f00ea7b1f86
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
98890
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Wed, 13 Mar 2024 07:46:17 GMT
head-back.jpg
www.biopharmaboardroom.com/bundles/taai/app/site/img/
88 KB
89 KB
Image
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/img/head-back.jpg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/bundles/taai/app/site/css/custom-style.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
7049761845bde0ce5ab4b2ca8a38a96b9f8783e46a1578bd008c8ec0e25c9352
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/custom-style.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:53 GMT
server
LiteSpeed
etag
"16104-641efd2d-f70b739b55468a2e;;;"
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
alt-svc
h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
content-length
90372
expires
Wed, 20 Mar 2024 07:46:17 GMT
cd-icon-close.svg
www.biopharmaboardroom.com/bundles/taai/app/site/img/
696 B
454 B
Image
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/img/cd-icon-close.svg
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/bundles/taai/app/site/css/custom-style.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/custom-style.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:49 GMT
server
LiteSpeed
etag
"2b8-641efd29-5643435d33f7934f;br"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
351
expires
Wed, 20 Mar 2024 07:46:17 GMT
fa-regular-400.woff2
www.biopharmaboardroom.com/bundles/taai/app/site/webfonts/
25 KB
25 KB
Font
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/webfonts/fa-regular-400.woff2
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/bundles/taai/app/site/css/all.min.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
fe69d94841462d397faeff253ee09a6dc7941be931f942a55e6b9def8f3b048d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Referer
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/all.min.css
Origin
https://www.biopharmaboardroom.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:58 GMT
server
LiteSpeed
etag
"6208-641efd32-41c4e8cc7cf434b3;;;"
content-type
font/woff2
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
25096
expires
Wed, 20 Mar 2024 07:46:17 GMT
fa-solid-900.woff2
www.biopharmaboardroom.com/bundles/taai/app/site/webfonts/
147 KB
147 KB
Font
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/webfonts/fa-solid-900.woff2
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/bundles/taai/app/site/css/all.min.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
d27bc752105c079f8a516e9142406a9fc12cbb409f9bf8681f2ddfe0360b52a6
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Referer
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/all.min.css
Origin
https://www.biopharmaboardroom.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:59 GMT
server
LiteSpeed
etag
"24bc8-641efd33-dc57e17f48c434f9;;;"
content-type
font/woff2
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
150472
expires
Wed, 20 Mar 2024 07:46:17 GMT
fa-brands-400.woff2
www.biopharmaboardroom.com/bundles/taai/app/site/webfonts/
105 KB
105 KB
Font
General
Full URL
https://www.biopharmaboardroom.com/bundles/taai/app/site/webfonts/fa-brands-400.woff2
Requested by
Host: www.biopharmaboardroom.com
URL: https://www.biopharmaboardroom.com/bundles/taai/app/site/css/all.min.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a02:4780:3:644:0:683:abf2:5 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
LiteSpeed /
Resource Hash
3fe890d088ecf0cc9bc1b9069201e52972dbad6237865524090e15982d0de718
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Referer
https://www.biopharmaboardroom.com/bundles/taai/app/site/css/all.min.css
Origin
https://www.biopharmaboardroom.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:17 GMT
content-security-policy
upgrade-insecure-requests
last-modified
Sat, 25 Mar 2023 13:54:58 GMT
server
LiteSpeed
etag
"1a3c4-641efd32-967d45f25aeaf559;;;"
content-type
font/woff2
cache-control
public, max-age=604800
accept-ranges
bytes
platform
hostinger
content-length
107460
expires
Wed, 20 Mar 2024 07:46:17 GMT
recaptcha__de.js
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/
494 KB
197 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.biopharmaboardroom.com/
Origin
https://www.biopharmaboardroom.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:25:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1220
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
200579
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:25:58 GMT
widget_iframe.2f70fb173b9000da126c79afe2098f02.html
platform.twitter.com/widgets/ Frame 8C48
319 KB
104 KB
Document
General
Full URL
https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fwww.biopharmaboardroom.com
Requested by
Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2606:2800:234:46c:e8b:1e2f:2bd:694 , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (frb/67BA) /
Resource Hash
70c00445d6632039ed99af760731daf3bf60eb12061863ee61e2cd7276a54d18

Request headers

Referer
https://www.biopharmaboardroom.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Access-Control-Allow-Methods
GET
Access-Control-Allow-Origin
*
Age
8000677
Cache-Control
public, max-age=315360000
Content-Encoding
gzip
Content-Length
105429
Content-Type
text/html; charset=utf-8
Date
Wed, 13 Mar 2024 07:46:18 GMT
Etag
"81267302efdfb3e4524a22631a8fc99e+gzip"
Last-Modified
Mon, 11 Dec 2023 17:19:49 GMT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server
ECS (frb/67BA)
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Vary
Accept-Encoding
X-Cache
HIT
x-amz-server-side-encryption
AES256
x-tw-cdn
VZ
collect
region1.google-analytics.com/g/
0
262 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-PHNZRXFXEX&gtm=45je43b0v9105491977za200&_p=1710315978079&gcd=13l3l3l2l1&npa=1&dma_cps=sypham&dma=1&cid=697568478.1710315978&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_s=1&sid=1710315978&sct=1&seg=0&dl=https%3A%2F%2Fwww.biopharmaboardroom.com%2Fnews%2F56%2F1631%2Ffujifilm-owen-technology-products-approved-expanding-reproductive-tech-in-china.html%3F__s%3D5slvqff6wv2m7m6e2l9i%26utm_source%3Ddrip%26utm_medium%3Demail%26utm_campaign%3DTakeda%2Band%2BBiological%2BE.%2BLimited%2BPartner%2Bto%2BEnhance%2BDengue%2BVaccine%2BAvailability%2Bin%2BHigh-Risk%2BRegions&dt=Fujifilm%20Owen%20Technology%20Products%20Approved%2C%20Expanding%20Reproductive%20Tech%20in%20China&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=1970
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-PHNZRXFXEX
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharmaboardroom.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 13 Mar 2024 07:46:18 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.biopharmaboardroom.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
settings
syndication.twitter.com/ Frame 8C48
869 B
658 B
Fetch
General
Full URL
https://syndication.twitter.com/settings?session_id=a4d230a2d88ad4cb71be4a93244cca8e02582823
Requested by
Host: platform.twitter.com
URL: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fwww.biopharmaboardroom.com
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.244.42.72 , United States, ASN13414 (TWITTER, US),
Reverse DNS
Software
tsa_o /
Resource Hash
302da628a6afc3e93f1b86bf7c65e4d6536d8283d78266964822a76d1c645aa4
Security Headers
Name Value
Strict-Transport-Security max-age=631138519

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://platform.twitter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

x-response-time
103
date
Wed, 13 Mar 2024 07:46:17 GMT
content-encoding
gzip
strict-transport-security
max-age=631138519
last-modified
Wed, 13 Mar 2024 07:46:18 GMT
server
tsa_o
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://platform.twitter.com
x-transaction-id
845cb6c555363a56
cache-control
must-revalidate, max-age=600
access-control-allow-credentials
true
perf
7469935968
x-connection-hash
a82831a37189767b66639ecbaddc9ddd34f4b2c0dc227ca4ea72d209b0a2f91d
content-length
337
anchor
www.google.com/recaptcha/api2/ Frame 61A3
46 KB
29 KB
Document
General
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=6d127scxyv0o
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
0137f645abebd28839c98252cd4f15791da016d6562eb534027428f65f372dc1
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-LcElo5-uZcQEW3_3L9bqVw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.biopharmaboardroom.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-LcElo5-uZcQEW3_3L9bqVw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 13 Mar 2024 07:46:18 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
anchor
www.google.com/recaptcha/api2/ Frame 583E
47 KB
29 KB
Document
General
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=58dotlukdv3d
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
3cad86140ab119e1ab4b41ade6203045848c6b7cc5617e7d85da97c39a239e07
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-YaOLonRQdMbftRr61n-Ucg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.biopharmaboardroom.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-YaOLonRQdMbftRr61n-Ucg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 13 Mar 2024 07:46:18 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 61A3
55 KB
24 KB
Stylesheet
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=6d127scxyv0o
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:27:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1147
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24606
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/css
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:27:11 GMT
recaptcha__de.js
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 61A3
494 KB
196 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=6d127scxyv0o
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:25:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1220
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
200579
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:25:58 GMT
styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 583E
55 KB
24 KB
Stylesheet
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=58dotlukdv3d
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:27:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1147
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24606
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/css
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:27:11 GMT
recaptcha__de.js
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 583E
494 KB
196 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=58dotlukdv3d
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:25:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1220
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
200579
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:25:58 GMT
Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js
www.google.com/js/bg/ Frame 583E
17 KB
7 KB
Script
General
Full URL
https://www.google.com/js/bg/Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
25e83b900afee29c01698c1861070e828fe2079b40386941a37e02928a02a3b0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=58dotlukdv3d
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 06 Mar 2024 08:14:52 GMT
content-encoding
br
x-content-type-options
nosniff
age
603086
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
7355
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 15:30:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 06 Mar 2025 08:14:52 GMT
Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js
www.google.com/js/bg/ Frame 61A3
17 KB
7 KB
Script
General
Full URL
https://www.google.com/js/bg/Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
25e83b900afee29c01698c1861070e828fe2079b40386941a37e02928a02a3b0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=6d127scxyv0o
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 06 Mar 2024 08:14:52 GMT
content-encoding
br
x-content-type-options
nosniff
age
603086
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
7355
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 15:30:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 06 Mar 2025 08:14:52 GMT
webworker.js
www.google.com/recaptcha/api2/ Frame 583E
102 B
134 B
Other
General
Full URL
https://www.google.com/recaptcha/api2/webworker.js?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=58dotlukdv3d
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
a8bfdecce5d2156da95876601ab50733e863513e3689ce32498a8370e79a5687
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=58dotlukdv3d
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
cross-origin-embedder-policy
require-corp
x-frame-options
SAMEORIGIN
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Wed, 13 Mar 2024 07:46:18 GMT
webworker.js
www.google.com/recaptcha/api2/ Frame 61A3
102 B
134 B
Other
General
Full URL
https://www.google.com/recaptcha/api2/webworker.js?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=6d127scxyv0o
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
a8bfdecce5d2156da95876601ab50733e863513e3689ce32498a8370e79a5687
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b&co=aHR0cHM6Ly93d3cuYmlvcGhhcm1hYm9hcmRyb29tLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=6d127scxyv0o
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:46:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
cross-origin-embedder-policy
require-corp
x-frame-options
SAMEORIGIN
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Wed, 13 Mar 2024 07:46:18 GMT
bframe
www.google.com/recaptcha/api2/ Frame 41E7
7 KB
1 KB
Document
General
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
6b68e59be288c11dfd0efd7a953b41858ced5225761a4f469779a5c9049952cb
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-2iY6iIG3Q7F6gV_3GXwIKQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.biopharmaboardroom.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-2iY6iIG3Q7F6gV_3GXwIKQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 13 Mar 2024 07:46:18 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
bframe
www.google.com/recaptcha/api2/ Frame AAA7
7 KB
1 KB
Document
General
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
f0b7697b568b634b0e2301457a9d6ef42800bd79d2cb15098623cbfed45d7ea5
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-4Ny3SG1LitP6O8WnzYzC2Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.biopharmaboardroom.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-4Ny3SG1LitP6O8WnzYzC2Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 13 Mar 2024 07:46:18 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 41E7
55 KB
24 KB
Stylesheet
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:27:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1147
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24606
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/css
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:27:11 GMT
recaptcha__de.js
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 41E7
494 KB
196 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:25:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1220
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
200579
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:25:58 GMT
styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame AAA7
55 KB
24 KB
Stylesheet
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:27:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1147
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24606
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/css
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:27:11 GMT
recaptcha__de.js
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame AAA7
494 KB
196 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LffSC4lAAAAADl212kFhGdU_-ZkfFoXyoSjcd7b
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 07:25:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1220
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
200579
x-xss-protection
0
last-modified
Mon, 04 Mar 2024 05:02:47 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 07:25:58 GMT

Verdicts & Comments Add Verdict or Comment

41 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 function| $ function| jQuery object| bootstrap object| html5 object| Modernizr function| pagination function| validateEmail function| allNumeric function| saveEnquiry function| getParameterByName string| passwrodLength function| validatePassword function| validateRegistration function| validateLogin function| validateForgotPassword function| isEmailExist function| validateNewsletter object| angular object| cms object| ___grecaptcha_cfg object| grecaptcha string| __recaptcha_api boolean| __google_recaptcha_client object| __twttrll object| twttr object| __twttr function| gtag object| dataLayer object| google_tag_manager object| google_tag_data function| onYouTubeIframeAPIReady object| gaGlobal object| recaptcha object| closure_lm_363515

3 Cookies

Domain/Path Name / Value
www.biopharmaboardroom.com/ Name: PHPSESSID
Value: dmo2hvv8uufsb29t7nuqnekbt6
.biopharmaboardroom.com/ Name: _ga_PHNZRXFXEX
Value: GS1.1.1710315978.1.0.1710315978.0.0.0
.biopharmaboardroom.com/ Name: _ga
Value: GA1.1.697568478.1710315978

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

fonts.googleapis.com
platform.twitter.com
region1.google-analytics.com
syndication.twitter.com
t.dripemail2.com
www.biopharmaboardroom.com
www.google.com
www.googletagmanager.com
www.gstatic.com
104.244.42.72
2001:4860:4802:32::36
2606:2800:234:46c:e8b:1e2f:2bd:694
2a00:1450:4001:803::200a
2a00:1450:4001:80b::2004
2a00:1450:4001:80e::2008
2a00:1450:4001:81c::2003
2a02:4780:3:644:0:683:abf2:5
34.200.173.115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